Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Geoff Chong"'
Autor:
Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoff Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Opat, Eliza A Hawkes
Publikováno v:
HemaSphere, Vol 7, p e24670ab (2023)
Externí odkaz:
https://doaj.org/article/e44f1b2473734afd9d926812ddcf5f35
Autor:
Rachel Koldej, Allison Barraclough, Sze Ting Lee, Huw Morgan, Nicholas Holzwart, Minu Koshy, Charmaine Smith, Geoff Chong, Michael Gilbertson, Colm Keane, Stephen Ting, Leonid Churilov, David Ritchie, Eliza A. Hawkes
Publikováno v:
HemaSphere, Vol 7, p e429662d (2023)
Externí odkaz:
https://doaj.org/article/7a665ad28913436a9ba38b1eafd40ba7
Autor:
Allison Barraclough, James T. England, Diego Villa, Joel Wight, Greg Hapgood, Jason Conn, Nicole Wong Doo, Eric Wenlong Li, Michael Gilbertson, Briony Shaw, Mark J. Bishton, Malik Saeed, Sumita Ratnasingam, Chathuri Abeyakoon, Geoff Chong, Shin Hnin Wai, Matthew Ku, Hui-Peng Lee, Kathryn Fleming, Constantine Tam, Genevieve Douglas, Chan Y. Cheah, Zi Yun Ng, Tukten Rolfe, Anthony K Mills, Nada Hamad, Helen Cashman, Mary Gleeson, Manjunath Narayana, Eliza A. Hawkes
Publikováno v:
Haematologica, Vol 108, Iss 9 (2023)
Grade (G) 3B follicular lymphoma (FL) is a rare FL subtype which exists on a histological continuum between ‘lowgrade’ (Grade 1, 2 and 3A FL) and diffuse large B-cell lymphoma (DLBCL) appearing to share features with each. Clinical characteristic
Externí odkaz:
https://doaj.org/article/83759b9a613345a6a23639746fdd8d71
Autor:
Mark Hertzberg, Maher K. Gandhi, Judith Trotman, Belinda Butcher, John Taper, Amanda Johnston, Devinder Gill, Shir-Jing Ho, Gavin Cull, Keith Fay, Geoff Chong, Andrew Grigg, Ian D. Lewis, Sam Milliken, William Renwick, Uwe Hahn, Robin Filshie, George Kannourakis, Anne-Marie Watson, Pauline Warburton, Andrew Wirth, John F. Seymour, Michael S. Hofman, Rodney J. Hicks
Publikováno v:
Haematologica, Vol 102, Iss 2 (2017)
In the treatment of diffuse large B-cell lymphoma, a persistently positive [18F]fluorodeoxyglucose positron emission tomography (PET) scan typically carries a poor prognosis. In this prospective multi-center phase II study, we sought to establish whe
Externí odkaz:
https://doaj.org/article/e5491b57b7b849d8b0c33b7f8a7661b1
Autor:
Hendrik-Tobias Arkenau, Geoff Chong, David Cunningham, David Watkins, Bhawna Sirohi, Ian Chau, Andrew Wotherspoon, Andy Norman, Alan Horwich, Estella Matutes
Publikováno v:
Haematologica, Vol 92, Iss 2 (2007)
Novel, effective therapies are needed for peripheral T-cell non-Hodgkin’s lymphoma (PTCL). We treated 16 patients with a combination of gemcitabine, cisplatin and methylprednisolone (GEM-P). Three patients (19%) achieved a complete remission and ei
Externí odkaz:
https://doaj.org/article/24e31318a9e049de99f39b43b63b76a8
Autor:
Jayesh Desai, Mark A. Rosen, Shirley S. Wong, Clayton A. Matthews, Annabell F. Leske, Gabriel Kremmidiotis, Geoff Chong, David C. Bibby, Danny Rischin
Purpose: To determine the recommended phase II dose and evaluate the safety and toxicity profile and pharmacokinetic (PK) and pharmacodynamic (PD) effects of BNC105P, an inhibitor of tubulin polymerization that has vascular disrupting and antiprolife
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f1bbb3cae0a7545d34a0051d68e8d2f
https://doi.org/10.1158/1078-0432.c.6519413
https://doi.org/10.1158/1078-0432.c.6519413
Autor:
Jayesh Desai, Mark A. Rosen, Shirley S. Wong, Clayton A. Matthews, Annabell F. Leske, Gabriel Kremmidiotis, Geoff Chong, David C. Bibby, Danny Rischin
PDF file - 66K, The pharmacokinetic parameters of BNC105 and BNC105P.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af603ef437e39000092338ce897079a
https://doi.org/10.1158/1078-0432.22442744.v1
https://doi.org/10.1158/1078-0432.22442744.v1
Autor:
Jayesh Desai, Mark A. Rosen, Shirley S. Wong, Clayton A. Matthews, Annabell F. Leske, Gabriel Kremmidiotis, Geoff Chong, David C. Bibby, Danny Rischin
PDF file - 191K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5289dd61852f228ac58df7d96ec75487
https://doi.org/10.1158/1078-0432.22442747
https://doi.org/10.1158/1078-0432.22442747
Autor:
Alberto F. Sobrero, Arvind Dasari, Sara Lonardi, Rocio Garcia-Carbonero, Elena Elez, Takayuki Yoshino, James C. Yao, Pilar Garcia-Alfonso, Judit Kocsis, Antonio Cubillo, Andrea Sartore-Bianchi, Taroh Satoh, Violaine Randrian, Jiri Tomasek, Geoff Chong, Zhao Yang, William R. Schelman, Marek K. Kania, Josep Tabernero, Cathy Eng
Publikováno v:
Journal of Clinical Oncology. 41:67-67
67 Background: The global phase 3 FRESCO-2 study, (NCT04322539) demonstrated that fruquintinib (F) vs placebo (P) significantly improved OS (HR=0.66 [95% CI: 0.55-0.80]; p
Autor:
Eliza Anne Hawkes, Kate Manos, Richard Khor, Genevieve Douglas, Sze Ting Lee, Denise Lee, Belinda Campbell, Anneke Grobler, Michael Gilbertson, Jodie Palmer, Geoff Chong
Publikováno v:
Journal of Clinical Oncology. 40:TPS7587-TPS7587
TPS7587 Background: Follicular lymphoma (FL) is the commonest indolent lymphoma, comprising 20% of non-Hodgkin Lymphoma, with approximately 80% of patients (pts) requiring therapy. At present, advanced stage is incurable; most pts require >1 treatmen